Continuing to deliver safe and high-quality care

Learning from clinical incidents

EMHS is very proud of the significant improvements we continue to make in providing safe and high-quality care for our patients and consumers. This is our number one priority.

It is recognised, however, that in such a complex and challenging industry, sometimes things can go wrong. We are committed to providing an open and transparent environment that includes supporting staff to report incidents in the event that something does not go according to plan.

During 2021-22, there were 141,793 patient admissions to EMHS hospitals. In addition, 213,508 patients were seen in our EDs and another 716,000 patients were seen in an outpatient clinic or setting.

As a testament to our professional and skilled workforce, the overwhelming majority of these interactions occurred without incident. However, for a very small percentage of patients, errors did regrettably occur during their care — and in some cases, these errors resulted in unintended harm.

In the interests of transparency, we are sharing the number of serious clinical incidents that occurred in 2021-22 at our hospitals and health services.

Every incident provides a critical learning opportunity that enables us to put in place strategies to prevent others from being harmed.

During 2021-22, there were 109 clinical incidents reported with a Severity Assessment Code (SAC) rating of 1 (SAC1). A SAC1 incident is a clinical incident that has, or could have, caused serious harm or death, and which is attributed to health care provision (or lack thereof) rather than the patient’s underlying condition or illness.

The number of SAC1 incidents is reflective of a strong culture of reporting. The most reported types of incidents include; infection control, mental health and patient accidents/falls incidents. All SAC1 clinical incidents are subject to a rigorous investigation with the reports being reviewed by members of the EMHS Executive, as well as the EMHS Board Safety and Quality Committee.

Morbidity and mortality (M&M) review is a forum for clinicians to openly and transparently discuss the quality of care provided to patients who have died or experienced significant morbidity while under the care of a health service. The EMHS has continued to mature and strengthen its M&M review processes. M&M review is an essential component of an integrated approach to identifying clinical incidents, opportunities for quality improvement and organisational learning through peer review.

EMHS has implemented a number of other initiatives to reduce the number and severity of SAC1 incidents. 

EMHS established a Reducing Falls with Harm Improvement Group to review and discuss patient falls in health care. EMHS sites shared current strategies in the prevention of harm from falls, including minimisation plans based on best practice and evidence to improve patient outcomes. The review of previous falls SAC1 recommendations was shared across EMHS, enabling sites to learn from past incidents.   

In 2021-22, EMHS introduced paediatric sepsis pathways across sites with paediatric services, resulting in an evidence-based and consistent approach to the identification and management of sepsis in the paediatric setting. Further implementation of inpatient adult sepsis pathways is also occurring.

EMHS participates in healthcare associated infection (HAIs) surveillance programs including the monitoring of hospital acquired blood stream infections (HABSI), enabling review of current practice. EMHS has created an HABSI action plan to reduce HAIs to ensure practice improvement and better patient outcomes. 

EMHS has implemented the Care Coordination in Mental Health Framework project, which revised and implemented a mental health framework of care and pathways to support consumers in a recovery orientated approach. A key aspect of the Care Coordination Framework aims to support consumers from point of entry or re-entry to discharge, to ensure there is a seamless transition from mental health services to the next point of care during this higher-risk period.  

Of the 109 serious incidents reported in 2021-22, the patient outcome1 was noted as:

7

no harm

2

minor harm

10

moderate harm

73

serious harm

death

1The outcome does not necessarily arise as a direct cause of the incident. Factors other than healthcare-related may have contributed to the patient’s outcome.

Learnings from a serious clinical incident

Situation

A patient with cognitive abilities was admitted for a surgical procedure following a recent fall. Upon admission multiple carers and family members were recorded within the patient demographic information system. However, the patient’s official state-appointed guardian was not included as next of kin. 

Following the procedure and subsequent discharge from the hospital, the patient developed an infection of the surgical site requiring further healthcare intervention. 

A lack of effective and clear patient information may have led to a missed opportunity for the patient and/or their official guardian to recognise and seek earlier assistance for symptoms of a surgical site infection.

Recommendation

The service (in conjunction with the Diversity and High-Risk Working Group) will develop a patient information leaflet (or similar) which outlines the risks of infection and advises patients on what to do if signs of infection develop post-discharge. This leaflet will cater to differing levels of health literacy.

Result

The outcome will be empowerment of patients to recognise and seek earlier assistance for symptoms of a surgical site infection, which may enable earlier treatment if infection is present.

L-R: Yang Lui, Sandra Miller, Bronagh Rice and Simon Scholes (EMHS Electronic Medication Management solution Team)
L-R: Yang Lui, Sandra Miller, Bronagh Rice and Simon Scholes (EMHS Electronic Medication Management solution Team)

New era of medication management on horizon

Plans to modernise the management of medications across EMHS moved a step closer to fruition in 2021-22.

It comes after an international medical software solutions company, with offices in Perth, was awarded a contract to design, build and commission EMHS’ Electronic Medication Management solution (EMMs).

The successful vendor was announced in June 2022 following a competitive tender process.

The new system will be customised to support the management of controlled substances and other high-risk medications across all EMHS sites, replacing current paper-based recordkeeping systems to enhance safety, efficiency, oversight, and accountability. 

Staff across our hospitals can expect to spend less time looking for medications and performing controlled substance transactions and discrepancy investigations once the new system is in place.

The system should improve patient safety by enhancing medication workflows. Other benefits of the EMMs will be automatic imprest ordering, improved inventory control and reduced wastage. 

The new system is expected to be ready for implementation by late 2022.